Evidence map›Paper›PMID 41888834›Full record

ArticleOrphanet journal of rare diseases2026

SERPINC1 mutations and thrombotic events in inherited antithrombin deficiency: a study on the han population of East China.

Fei Xu, Xiaoli Chen, Qiyu Xu, Anqing Zou, Xiaolong Li, Mingshan Wang, Lihong Yang, Haixiao Xie

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fei XuDepartment of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xiaoli ChenDepartment of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Shangcai Village, Ouhai District, Wenzhou, Zhejiang, China.
Qiyu XuDepartment of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Anqing ZouDepartment of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xiaolong LiDepartment of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Mingshan WangDepartment of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Lihong YangDepartment of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. YLH91@163.com.
Haixiao XieDepartment of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. wyxiehaixiao@163.com.

Funding

the Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province 2022E10022Zhengzhou Municipal Science and Technology Bureau Y20220126
6 · The paper itself

Abstract

backgroundInherited antithrombin deficiency (ATD), a rare autosomal dominant disorder due to SERPINC1 gene mutations, is the most severe inherited thrombophilia. Limited literature exists that focuses on ATD and its mutations in the Chinese population. This study aimed to characterize SERPINC1 gene mutations in a Chinese cohort and to explore their relationship with thrombophilia.

methodsCoagulation screening results and clinical data were meticulously collected from 23 unrelated probands with ATD and their family members. Genomic DNA was extracted and subjected to PCR amplification and direct sequencing. Putative mutations were analyzed using in silico bioinformatic tools. Mutant antithrombin (AT) proteins were expressed in HEK293 cells, and ELISA was used to detect wild-type and mutant AT. RT-qPCR was used to measure AT mRNA expression in transfected cells.

resultsAmong the 23 probands, 15 (65.2%) exhibited concurrent reductions in both AT: A and AT: Ag (type I defects), while the remaining 8 (34.8%) had normal AT: Ag levels (type II defects). Genetic analysis revealed a spectrum of 21 distinct mutations across 87.0% (20/23) of the probands. Most were point mutations predicted to be deleterious and were primarily located in exons 5 and 3. Among the 20 mutation carriers, 15 (75%) were heterozygous and most of them experienced thrombosis with identifiable triggers. The other 5 (25%) were compound heterozygous and primarily presented with spontaneous thrombosis. Notably, the missense mutations c.1346T > A and c.442T > C were recurrent. These mutations exhibited high heterogeneity, with no ethnic-specific mutations observed. In vitro expression confirmed that synthesis and/or secretion defects in the mutant proteins are the primary mechanism underlying the antithrombin deficiency.

conclusionsSERPINC1 gene analysis benefits asymptomatic family members, especially child-bearing women, by informing venous thromboembolism prevention strategies and guiding anticoagulant choice in cases involving heparin-binding site mutations. This underscores the essential role of genetic diagnosis in ATD management.

Indexed as

Antithrombin IIIAntithrombin III DeficiencyMutationThrombosisAdolescentAdultChildChild, PreschoolChinaEast Asian PeopleFemaleHEK293 CellsHumansMaleMiddle AgedYoung AdultAntithrombin IIISERPINC1 protein, humanAntithrombin deficiencyIn silico bioinformatic toolsMutationSERPINC1 geneThrombophilia

Identifiers

PMID41888834
PMCPMC13020232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.